140 related articles for article (PubMed ID: 12764754)
1. Dramatic response of multiply relapsed hepatoblastoma to irinotecan (CPT-11).
Palmer RD; Williams DM
Med Pediatr Oncol; 2003 Jul; 41(1):78-80. PubMed ID: 12764754
[No Abstract] [Full Text] [Related]
2. [Preliminary study on the efficacy of irinotecan in the treatment of childhood relapsed hepatoblastoma].
Chang J; Zhang YT; Zhong XD; Wang LZ
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jul; 15(7):588-90. PubMed ID: 23866285
[No Abstract] [Full Text] [Related]
3. Response of heavily treated and relapsed hepatoblastoma in the transplanted liver to single-agent therapy with irinotecan.
Ijichi O; Ishikawa S; Shinkoda Y; Tanabe T; Okamoto Y; Takamatsu H; Inomata Y; Kawano Y
Pediatr Transplant; 2006 Aug; 10(5):635-8. PubMed ID: 16857004
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma--a phase II trial of the childhood liver tumour strategy group (SIOPEL).
Zsíros J; Brugières L; Brock P; Roebuck D; Maibach R; Child M; Morland B; Casanova M; Pariente D; Paris C; de Camargo B; Ronghe M; Zimmermann A; Plaschkes J; Czauderna P; Perilongo G
Eur J Cancer; 2012 Dec; 48(18):3456-64. PubMed ID: 22835780
[TBL] [Abstract][Full Text] [Related]
5. Sustained Remission After Maintenance Irinotecan in Patient With Multiply Relapsed Hepatoblastoma.
Natarajan E; Auerbach C; Cheron R; Pashankar F
J Pediatr Hematol Oncol; 2020 Oct; 42(7):e659-e661. PubMed ID: 31259823
[TBL] [Abstract][Full Text] [Related]
6. Irinotecan as maintenance therapy in high-risk hepatoblastoma.
Qayed M; Powell C; Morgan ER; Haugen M; Katzenstein HM
Pediatr Blood Cancer; 2010 May; 54(5):761-3. PubMed ID: 20063426
[TBL] [Abstract][Full Text] [Related]
7. [Effect of chemotherapy using irinotecan (CPT-11) against recurrent colorectal cancer].
Nishimura G; Satou T; Yoshimitsu Y; Kurosaka Y; Fujimura T; Sugiyama K; Kanno M; Yonemura Y; Miwa K; Miyazaki I
Gan To Kagaku Ryoho; 1995 Jan; 22(1):93-7. PubMed ID: 7826085
[TBL] [Abstract][Full Text] [Related]
8. [Irinotecan hydrochloride (CPT-11) for advanced cervical cancer].
Terauchi F
Nihon Rinsho; 2004 Oct; 62 Suppl 10():175-8. PubMed ID: 15535228
[No Abstract] [Full Text] [Related]
9. Successful clinical response to irinotecan in relapsed neuroblastoma.
Shitara T; Shimada A; Tsuchida Y; Suzuki N; Toki F; Kuroiwa M
Med Pediatr Oncol; 2003 Feb; 40(2):126-8. PubMed ID: 12461801
[No Abstract] [Full Text] [Related]
10. Novel therapeutic approaches in the treatment of children with hepatoblastoma.
Katzenstein HM; Rigsby C; Shaw PH; Mitchell TL; Haut PR; Kletzel M
J Pediatr Hematol Oncol; 2002 Dec; 24(9):751-5. PubMed ID: 12468918
[TBL] [Abstract][Full Text] [Related]
11. [Irinotecan chemotherapy for patients with advanced or relapsed pancreatic neoplasm].
Sekikawa T; Akaike A; Ushio J; Sato A; Matsukawa M
Nihon Rinsho; 2006 Jan; 64 Suppl 1():203-6. PubMed ID: 16457250
[No Abstract] [Full Text] [Related]
12. Relapsed hepatoblastoma.
Trobaugh-Lotrario AD; Feusner JH
Pediatr Blood Cancer; 2012 Nov; 59(5):813-7. PubMed ID: 22648963
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group.
O'Neill AF; Towbin AJ; Krailo MD; Xia C; Gao Y; McCarville MB; Meyers RL; McGahren ED; Tiao GM; Dunn SP; Langham MR; Weldon CB; Finegold MJ; Ranganathan S; Furman WL; Malogolowkin M; Rodriguez-Galindo C; Katzenstein HM
J Clin Oncol; 2017 Oct; 35(30):3465-3473. PubMed ID: 28892430
[TBL] [Abstract][Full Text] [Related]
14. [Induction of CPT-11 in a patient on hemodialysis with metastatic rectal cancer].
Shinozaki E; Mizunuma N; Tanabe M; Chin K; Ota K; Ohkochi N; Hatake K
Gan To Kagaku Ryoho; 2005 Mar; 32(3):397-9. PubMed ID: 15791826
[TBL] [Abstract][Full Text] [Related]
15. [Low-dose CPT-11 against a recurrent rectal cancer--a case report].
Takahashi Y; Omote K; Kitagata S; Mai M
Gan To Kagaku Ryoho; 1999 Jul; 26(8):1193-6. PubMed ID: 10431589
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of irinotecan in children with relapsed or refractory rhabdomyosarcoma: a joint study of the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group.
Vassal G; Couanet D; Stockdale E; Geoffray A; Geoerger B; Orbach D; Pichon F; Gentet JC; Picton S; Bergeron C; Cisar L; Assadourian S; Morland B; ;
J Clin Oncol; 2007 Feb; 25(4):356-61. PubMed ID: 17264330
[TBL] [Abstract][Full Text] [Related]
17. [Late phase II study of irinotecan hydrochloride (CPT-11) in advanced gastric cancer. CPT-11 Gastrointestinal Cancer Study Group].
Futatsuki K; Wakui A; Nakao I; Sakata Y; Kambe M; Shimada Y; Yoshino M; Taguchi T; Ogawa N
Gan To Kagaku Ryoho; 1994 Jun; 21(7):1033-8. PubMed ID: 8210254
[TBL] [Abstract][Full Text] [Related]
18. [A late phase II study of CPT-11, irinotecan hydrochloride, in patients with advanced pancreatic cancer. CPT-11 Study Group on Gastrointestinal Cancer].
Sakata Y; Shimada Y; Yoshino M; Kambe M; Futatsuki K; Nakao I; Ogawa N; Wakui A; Taguchi T
Gan To Kagaku Ryoho; 1994 Jun; 21(7):1039-46. PubMed ID: 8210255
[TBL] [Abstract][Full Text] [Related]
19. Irinotecan as a maintenance therapy for hepatoblastoma: a comment.
Wiwanitkit V
J Cancer Res Ther; 2010; 6(4):588. PubMed ID: 21358112
[No Abstract] [Full Text] [Related]
20. Treatment of advanced or recurrent colorectal cancer with irinotecan in Japan and elsewhere.
Sato T; Hatate K; Ikeda A; Yamanashi T; Ozawa H; Onosato W; Nakamura T; Ihara A; Watanabe M
Expert Opin Pharmacother; 2008 May; 9(7):1223-8. PubMed ID: 18422478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]